Many genetic lung diseases have associated complications involving other organs that, if detected early, can be treated effectively.
Early diagnosis is important for preserving lung function. Once a diagnosis of any type of rare lung disease is confirmed, patients will be closely monitored for the development of complications, including lung infection, pneumothorax (collapsed lung), or end-stage lung disease. Earlier diagnosis, leading to earlier initiation of preventative therapies, can improve long-term lung health.
Here are a few of the most common diseases Tested in Pulmonary Panel:
- Cystic Fibrosis
- Central Hypoventilation Syndrome
- Pulmonary arterial hypertension
- Ret gene mutation can cause lung cancer
- Chronic Obstructive Pulmonary disease
- Bronchiectasis
- Neuroendocrine Lung tumors
- Tuberous Sclerosis
- Lymphangioleiomyomatosis Disease
- Pulmonary Surfactant Dysfunction
- Interstitial Lung Disease
- Congenital Hypoventilation Syndrome
- Primary Ciliary
- Dyskinesia Ciliary Dyskinesia
- Kartagener Syndrome
- Emphysema
- Pneumothorax (Spontaneous Pneumothorax)
- Pulmonary Fibrosis
- Asthma
- Respiratory Distress Syndrome
- Pulmonary Hypertension
- Serpinal Mutations can lead to AAT deficiency which is associated with a substantially increased risk of lung disease
Panels that are offered at Tesis Biosciences include:
- Pulmonary Arterial Hypertension
- Cystic Lung Disease
- Lung Disorders Comprehensive

